Nachrichten zur Pacira BioSciences Aktie

Insiderhandel: Aufsichtsrat verkauft Aktien von Pacira BioSciences im Wert von 722.600$

Longenecker, John P Phd - Aufsichtsrat - Tag der Transaktion: 2021-03-01...…

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…

Pacira BioSciences, Inc.: 10-K Report

10-K - PCRX - 12.31.2020...…

Pacira BioSciences, Inc. (PCRX) Q4 2020 Earnings Call Transcript

PCRX earnings call for the period ending December 31, 2020....…

Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q4 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira (PCRX) Q4 Earnings Beat Estimates

Pacira (PCRX) delivered earnings and revenue surprises of 6.10% and -0.89%, respectively, for the quarter ended December 2020. Do the…

Pacira BioSciences, Inc.: 8-K Report

8-K...…

Pacira BioSciences Q4 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira to Report 2020 Financial Results on Thursday February 25, 2021

PARSIPPANY, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report…

Pacira BioSciences reports January prelim net product sales

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021

EXPAREL average daily sales at 108% of the prior year for the month of January 2021 EXPAREL average daily sales…

Pacira BioSciences, Inc.: 8-K Report

8-K...…

Insiderhandel: President verkauft Aktien von Pacira Pharmaceuticals im Wert von 6.689 $

Reinhardt, Max - Vorstand - Tag der Transaktion: 2021-01-06...…

Pacira BioSciences reports subdued growth for 2020

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira BioSciences, Inc.: 8-K Report

8-K...…

Pacira Reports Record Revenue for 2020 of $429.6 Million

-- EXPAREL average daily sales at 109% of the prior year for the fourth quarter and 111% of the prior…

Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…

Pacira BioSciences, Inc.: 8-K Report

8-K...…

Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020

-- EXPAREL average daily sales at 103% of the prior year for the month of November 2020 -- PARSIPPANY, N.J.,…

Pacira BioSciences to Present at the 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference

PARSIPPANY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…

Pacira (PCRX) Gets European Commission Approval for Exparel

The EC approves Paciras (PCRX) Exparel for treating post-operative pain in adults and as a field block for treating somatic…

Pacira Receives European Commission Approval for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain

--Approval based on four pivotal studies showing EXPAREL reduced pain scores and opioid use following surgery-- --EXPAREL is the first…

Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020

-- EXPAREL average daily sales at 112% of the prior year for the month of October 2020 -- -- EXPAREL…

Pacira BioSciences, Inc.: 10-Q Report

10-Q - PCRX - 9.30.2020...…

Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q3 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira BioSciences, Inc. 2020 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira (PCRX) Beats Q3 Earnings and Revenue Estimates

Pacira (PCRX) delivered earnings and revenue surprises of 3.03% and 1.90%, respectively, for the quarter ended September 2020. Do the…

Pacira BioSciences Q3 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira BioSciences (PCRX) Enters Oversold Territory

Pacira BioSciences (PCRX) has been on a bit of a cold streak lately, but there might be light at the…

Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute Pain

--The Pacira Innovation and Training Center of Tampa will provide clinicians with a flexible environment for hands-on learning-- PARSIPPANY, N.J.,…

Pacira to Report Third Quarter 2020 Financial Results on Thursday October 29, 2020

PARSIPPANY, N.J., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report…

Is Pacira BioSciences (PCRX) Outperforming Other Medical Stocks This Year?

Is (PCRX) Outperforming Other Medical Stocks This Year?...…

Insiderhandel: CEO and Chairman verkauft Aktien von Pacira Pharmaceuticals im Wert von 1.666.800 $

Stack, David M. - CEO and Chairman - Tag der Transaktion: 2020-10-16...…

Insiderhandel: CEO and Chairman verkauft Aktien von Pacira Pharmaceuticals im Wert von 1.650.000 $

Stack, David M. - CEO and Chairman - Tag der Transaktion: 2020-10-15...…

Insiderhandel: CEO and Chairman verkauft Aktien von Pacira Pharmaceuticals im Wert von 1.665.900 $

Stack, David M. - CEO and Chairman - Tag der Transaktion: 2020-10-14...…

Pacira Bio sees Exparel sales of $113.7M for Q3 2020

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020

-- EXPAREL average daily sales at 110% of the prior year for the third quarter and 110% of the prior…

Pacira BioSciences: Products And Management Can Maintain Outperformance Despite Q2 Sales Decline

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira (PCRX) Gains Positive CHMP Opinion for Exparel in EU

The CHMP gives a positive opinion recommending an approval for Paciras (PCRX) Exparel (bupivacaine liposome injectable suspension) to treat postsurgical…

Pacira Biosciences (PCRX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pacira Receives Positive CHMP Opinion for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain

-- CHMP opinion supported by four pivotal studies showing EXPAREL reduced pain scores and opioid use following surgery -- -- European…